Immune checkpoint inhibitor outcomes and prognostic factors in gynecologic tract melanoma: a single-center analysis
IntroductionGynecologic tract melanoma (GTM) is a rare and aggressive malignancy with limited treatment options and poor prognosis. This study aims to evaluate the outcomes of immune checkpoint inhibitors (ICIs) in patients with GTM and identify prognostic factors influencing survival.MethodsA retro...
Saved in:
| Main Authors: | Jianzhang Wang, Kemin Li, Rui Li, Jing Zeng, Rutie Yin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1542293/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AKT inhibitors in gynecologic oncology: past, present and future
by: Jinghong Chen, et al.
Published: (2025-07-01) -
Frequency of microsatellite instability in gynecologic cancers and the efficacy of immune checkpoint inhibitors treated: real-world data from a single gynecologic center
by: Wei Kuang, et al.
Published: (2025-05-01) -
A critical review of the progress in prevention and treatment of radiation-induced skin damage
by: Li Kemin, et al.
Published: (2024-11-01) -
Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes
by: Zexing Shan, et al.
Published: (2024-07-01) -
Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy
by: Estelle Tran Van Hoi, et al.
Published: (2024-11-01)